ValGenesis, Inc. and AUSTAR have partnered to deploy digital, risk-based solutions for life sciences companies in China. AUSTAR is a technology-based pharmaceutical engineering solutions provider with deep understanding of industry regulations and processes. The company is committed to helping clients improve process and operational effectiveness through boosting global drug safety and efficacy to protect and promote human health.

ValGenesis' end-to-end digital validation platform, which includes its VLMS offering, helps the world's leading life sciences companies enable stronger compliance, enforce standardization, and further digital transformation across manufacturing operations. ValGenesis and AUSTAR recently implemented ValGenesis iRisk at two large drug manufacturing centers in China, helping them strengthen risk and compliance across development and manufacturing operations. ValGenesis iRisk helps companies effectively assess and manage risk throughout a product's lifecycle in a fully digital, purpose-built application.